Neurological presentation of Wilson's disease in a patient after liver transplantation

Movement Disorders

Volumn 23, Issue 5, 2008, Pages 743-746

  Litwin, Tomasz ^a   Gromadzka, Grazyna ^a,b   Członkowska, Anna ^a,b  

^a INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Central pontine myelinolysis; Liver transplantation; Wilson's disease

Indexed keywords

CERULOPLASMIN; COPPER; CYCLOSPORIN A; PENICILLAMINE; TACROLIMUS; ZINC SULFATE;

ADULT; ARTICLE; CASE REPORT; CENTRAL PONTINE MYELINOLYSIS; CERULOPLASMIN BLOOD LEVEL; COLON DISEASE; COMA; COPPER BLOOD LEVEL; COPPER METABOLISM; DISEASE COURSE; DISEASE SEVERITY; DNA SEQUENCE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSARTHRIA; DYSPHAGIA; DYSTONIA; GENETIC ANALYSIS; GRAFT REJECTION; HEMOLYTIC ANEMIA; HEPATIC ENCEPHALOPATHY; HETEROZYGOSITY; HUMAN; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MISSENSE MUTATION; MUSCLE DISEASE; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOTHERAPY; POSTOPERATIVE CARE; PRIORITY JOURNAL; REHABILITATION CARE; SPEECH THERAPY; URINARY EXCRETION; WILSON DISEASE; BLOOD; PATHOLOGY; PONS; REMISSION; URINE;

ADULT; COPPER; DISEASE PROGRESSION; HEPATOLENTICULAR DEGENERATION; HUMANS; LIVER TRANSPLANTATION; MAGNETIC RESONANCE IMAGING; MALE; PONS; REMISSION INDUCTION; ZINC SULFATE;

EID: 44449169800     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21913     Document Type: Article

References (14)

1. Ala A, Walker AP, Ashkan K, Dooley JS, Schilsky ML. Wilson's disease. Lancet 2007;369:397-408.
2. Brewer GJ, Askari FK. Wilson's disease: clinical management and therapy. J Hepatol 2005;42:13-21.
3. Medici V, Mirante VG, Fassati LR, et al.; Monotematica AISF 2000 OLT Study Group. Liver transplantation for Wilson's disease: the burden of neurological and psychiatric disorders. Liver Transpl 2005;11:1056-1063.
4. Czlonkowska A, Tarnacka B, Litwin T, Gajda J, Rodo M. Wilson's disease - cause of mortality in 164 patients during the 1992-2003 observation period. J Neurol 2005;252:698-703.
5. Senzolo M, Loreno M, Fagiuoli S, et al. Different neurological outcome of liver transplantation for Wilson's disease in two homozygotic twins. Clin Neurol Neurosurg 2007;109:71-75.
6. Yu J, Zheng SS, Liang TB, Shen Y, Wang WL, Ke QH. Possible causes of central pontine myelinolysis after liver transplantation. World J Gastroenterol 2004;10:2540-2543.
7. King AD, Walshe JM, Kendall BE, et al. Cranial MR findings in Wilson's disease. Am J Roentgenol 1996;167:1579-1584.
8. Kizkin S, Sarac K, Cemal O. Central pontine myelinolysis in Wilson's disease: MR spectroscopy findings. Magn Reson Imaging 2004;22:117-121.
9. Imiya M, Ichikawa K, Matsushima H, Kageyama Y, Fuijoka A. MR of the base of the pons in Wilson's disease. Am J Neuroradiol 1992;13:1009-1012.
10. Bird GL, Meadows J, Goka J, Polson R, Wiliams R. Cyclosporin-associated akinetic mutism and extrapyramidal syndrome after liver transplantation. J Neurol Neurosurg Psychiatry 1990;53: 1068-1071.
11. Fryer JP, Fortier MV, Metrakos P, et al. Central pontine myelinolysis and cyclosporine neurotoxicity following liver transplantation. Transplantation 1996;61:658-661.
12. Fuat SH, Yanli G, Minouchehr S, et al. Neurological complications after cadaveric and living donor transplantation. J Neurol 2006; 253:612-617.
13. Ponticelli C, Campise MR. Neurological complications in kidney transplant recipients. J Nephrol 2005;18:521-528.
14. Geissler I, Heinemann K, Rohm S, Hauss J, Lamesch P. Liver transplantation for hepatic and neurological Wilson's disease. Transplant Proc 2003;35:1445-1446.